Pharmacological targeting of the pseudokinase Her3

Nat Chem Biol. 2014 Dec;10(12):1006-12. doi: 10.1038/nchembio.1658. Epub 2014 Oct 19.

Abstract

Her3 (also known as ErbB3) belongs to the epidermal growth factor receptor tyrosine kinases and is well credentialed as an anti-cancer target but is thought to be 'undruggable' using ATP-competitive small molecules because it lacks appreciable kinase activity. Here we report what is to our knowledge the first selective Her3 ligand, TX1-85-1, that forms a covalent bond with Cys721 located in the ATP-binding site of Her3. We demonstrate that covalent modification of Her3 inhibits Her3 signaling but not proliferation in some Her3-dependent cancer cell lines. Subsequent derivatization with a hydrophobic adamantane moiety demonstrates that the resultant bivalent ligand (TX2-121-1) enhances inhibition of Her3-dependent signaling. Treatment of cells with TX2-121-1 results in partial degradation of Her3 and serendipitously interferes with productive heterodimerization between Her3 with either Her2 or c-Met. These results suggest that small molecules will be capable of perturbing the biological function of Her3 and ∼60 other pseudokinases found in human cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylamides / chemical synthesis
  • Acrylamides / pharmacology*
  • Adamantane / chemistry
  • Adenine / analogs & derivatives*
  • Adenine / chemical synthesis
  • Adenine / pharmacology
  • Adenosine Triphosphate / chemistry
  • Adenosine Triphosphate / metabolism
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology*
  • Catalytic Domain
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cysteine / chemistry
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Molecular Docking Simulation
  • Molecular Targeted Therapy
  • Protein Kinase Inhibitors / chemical synthesis
  • Protein Kinase Inhibitors / pharmacology*
  • Protein Multimerization
  • Proteolysis
  • Proto-Oncogene Proteins c-met / chemistry*
  • Proto-Oncogene Proteins c-met / genetics
  • Proto-Oncogene Proteins c-met / metabolism
  • Receptor, ErbB-2 / chemistry*
  • Receptor, ErbB-2 / genetics
  • Receptor, ErbB-2 / metabolism
  • Receptor, ErbB-3 / antagonists & inhibitors*
  • Receptor, ErbB-3 / chemistry
  • Receptor, ErbB-3 / genetics
  • Signal Transduction

Substances

  • Acrylamides
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • TX1-85-1
  • Adenosine Triphosphate
  • ERBB2 protein, human
  • ERBB3 protein, human
  • Proto-Oncogene Proteins c-met
  • Receptor, ErbB-2
  • Receptor, ErbB-3
  • Adenine
  • Cysteine
  • Adamantane